First Time Loading...
W

Walvax Biotechnology Co Ltd
SZSE:300142

Watchlist Manager
Walvax Biotechnology Co Ltd
SZSE:300142
Watchlist
Price: 15.12 CNY 0.2% Market Closed
Updated: May 9, 2024

Walvax Biotechnology Co Ltd
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Walvax Biotechnology Co Ltd
Cash from Financing Activities Peer Comparison

Comparables:
6160
1801
603392
300122
300896

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
W
Walvax Biotechnology Co Ltd
SZSE:300142
Cash from Financing Activities
¥236.6m
CAGR 3-Years
3%
CAGR 5-Years
-20%
CAGR 10-Years
-16%
Beigene Ltd
HKEX:6160
Cash from Financing Activities
-¥448.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Cash from Financing Activities
¥2.9B
CAGR 3-Years
-16%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Cash from Financing Activities
-¥893.3m
CAGR 3-Years
N/A
CAGR 5-Years
-98%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Cash from Financing Activities
-¥2.4B
CAGR 3-Years
-5%
CAGR 5-Years
N/A
CAGR 10-Years
-39%
Imeik Technology Development Co Ltd
SZSE:300896
Cash from Financing Activities
-¥374.2m
CAGR 3-Years
-104%
CAGR 5-Years
-98%
CAGR 10-Years
N/A

See Also

What is Walvax Biotechnology Co Ltd's Cash from Financing Activities?
Cash from Financing Activities
236.6m CNY

Based on the financial report for Dec 31, 2023, Walvax Biotechnology Co Ltd's Cash from Financing Activities amounts to 236.6m CNY.

What is Walvax Biotechnology Co Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-16%

Over the last year, the Cash from Financing Activities growth was 150%. The average annual Cash from Financing Activities growth rates for Walvax Biotechnology Co Ltd have been 3% over the past three years , -20% over the past five years , and -16% over the past ten years .